GB9410907D0 - Anti-cancer compounds - Google Patents
Anti-cancer compoundsInfo
- Publication number
- GB9410907D0 GB9410907D0 GB9410907A GB9410907A GB9410907D0 GB 9410907 D0 GB9410907 D0 GB 9410907D0 GB 9410907 A GB9410907 A GB 9410907A GB 9410907 A GB9410907 A GB 9410907A GB 9410907 D0 GB9410907 D0 GB 9410907D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cancer compounds
- cancer
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939311717A GB9311717D0 (en) | 1993-06-07 | 1993-06-07 | Anti-cancer compounds |
GB939311719A GB9311719D0 (en) | 1993-06-07 | 1993-06-07 | Anti-cancer compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
GB9410907D0 true GB9410907D0 (en) | 1994-07-20 |
GB2278843A GB2278843A (en) | 1994-12-14 |
Family
ID=26303016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9410907A Withdrawn GB2278843A (en) | 1993-06-07 | 1994-06-01 | Anti-cancer compounds |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU6803494A (en) |
GB (1) | GB2278843A (en) |
WO (1) | WO1994029327A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2222455T3 (en) * | 1994-01-28 | 2005-02-01 | University Of Kentucky Research Foundation | COPHARMACOS AS A METHOD OF CONTROLLED RELEASE OF PHARMACOS. |
JP4903922B2 (en) * | 1997-05-14 | 2012-03-28 | スローン − ケッタリング インスティチュート フォー キャンサー リサーチ | Complex compounds that degrade selected proteins |
FR2818908B1 (en) * | 2000-12-29 | 2004-04-02 | Dospharma | USE AS A MEDICAMENT OF A COMPOUND RESTITUTING IN VIVO ACTIVE INGREDIENTS |
AU2003205278B2 (en) * | 2002-01-18 | 2008-08-07 | Psivida Us Inc. | Polymeric gel system for the controlled delivery of codrugs |
CN102219812B (en) * | 2011-04-14 | 2014-04-09 | 中国药科大学 | Tumor targeting deoxyglucose composite drug and preparation method thereof |
MX2018002514A (en) * | 2015-09-22 | 2018-08-15 | Univ California | Modified cytotoxins and their therapeutic use. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2201419A (en) * | 1987-02-24 | 1988-09-01 | Erba Farmitalia | Anthracycline-oestrone derivatives |
DE3907290A1 (en) * | 1989-03-07 | 1990-09-13 | Gerhard Prof Dr Eisenbrand | STEROID HORMONE RECEPTOR AFFINES ANTITUARY ACTIVE SUBSTANCES |
US5149794A (en) * | 1990-11-01 | 1992-09-22 | State Of Oregon | Covalent lipid-drug conjugates for drug targeting |
AU1424492A (en) * | 1991-02-20 | 1992-09-15 | Christopher Capelli | Non-protein intracellular receptor binding conjugates and a method of use thereof |
-
1994
- 1994-06-01 AU AU68034/94A patent/AU6803494A/en not_active Abandoned
- 1994-06-01 WO PCT/GB1994/001185 patent/WO1994029327A1/en active Application Filing
- 1994-06-01 GB GB9410907A patent/GB2278843A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO1994029327A1 (en) | 1994-12-22 |
AU6803494A (en) | 1995-01-03 |
GB2278843A (en) | 1994-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9304620D0 (en) | Compounds | |
GB2265148B (en) | Anti-cancer compounds | |
GB2253849B (en) | Anti-cancer compounds | |
GB9302016D0 (en) | Compounds | |
GB9410907D0 (en) | Anti-cancer compounds | |
GB9307400D0 (en) | Compounds | |
GB9207958D0 (en) | Anti-cancer compounds | |
GB9311717D0 (en) | Anti-cancer compounds | |
GB9311719D0 (en) | Anti-cancer compounds | |
EP0733044A4 (en) | Compounds | |
GB9201913D0 (en) | Anti-cancer compounds | |
GB9218051D0 (en) | Anti-cancer compounds | |
GB9205908D0 (en) | Anti-cancer compounds | |
IL108295A0 (en) | Anti-cancer compounds | |
GB9307044D0 (en) | Anti-cancer agents | |
GB9107794D0 (en) | Anti-cancer compounds | |
GB9107845D0 (en) | Anti-cancer compounds | |
GB9107844D0 (en) | Anti-cancer compounds | |
GB9105836D0 (en) | Anti-cancer compounds | |
GB9107837D0 (en) | Anti-cancer compounds | |
GB9107978D0 (en) | Anti-cancer compounds | |
GB9306434D0 (en) | Compounds | |
GB9309618D0 (en) | Compounds | |
GB9302636D0 (en) | Compounds | |
GB9303808D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |